SQA

OCTOBER 18, 2024

This precautionary measure adopted by the agency aims to ensure the health and physical integrity of the Brazilian population since, to date, no studies have been presented to ANVISA that prove the effectiveness and safety of the phenol product for use in such procedures.

FDA 40

FDA Compliance Public Health Governance 40

SQA

AUGUST 1, 2024

The adoption of these mechanisms is recommended and encouraged by the World Health Organization (WHO) so that the population has faster access to health services and technologies. In addition, the ISPE Guide outlines the authority of State Boards of Pharmacy and their coordination of oversight with the FDA.

FDA 40

FDA Licensing Compliance World Health 40

SQA

AUGUST 8, 2023

The main innovations presented in the new standard are: Increased scope of the standard, with the inclusion of anatomopathological and toxicology laboratories, among others. PCPC has long supported providing the FDA with the resources it needs to advance modern federal regulatory oversight of cosmetics and personal care products.

FDA 40

FDA Compliance COVID-19 World Health 40

SQA

AUGUST 8, 2023

The main innovations presented in the new standard are: Increased scope of the standard, with the inclusion of anatomopathological and toxicology laboratories, among others. PCPC has long supported providing the FDA with the resources it needs to advance modern federal regulatory oversight of cosmetics and personal care products.

FDA 40

FDA Compliance COVID-19 World Health 40

SQA

OCTOBER 18, 2023

The US FDA has already recognized the ability of 16 EU Member States to conduct GMP inspections of manufacturers of veterinary medicinal products. At the same time, the EU has recognized the US FDA as an equivalent authority to carry out these inspections. about how they use sunscreen products.

FDA 40

FDA Compliance Licensing World Health 40

SQA

OCTOBER 18, 2023

At the same time, the EU has recognized the US FDA as an equivalent authority to carry out these inspections. This extends the earlier 31 December 2023 deadline, which requires medicines for Great Britain (GB) to be presented in GB compliant packaging. about how they use sunscreen products.

FDA 40

FDA Compliance Licensing World Health 40

SQA

JULY 8, 2022

The ICH E8(R1) Introductory Training Presentation Now Available on the ICH Website, 27 April 2022. A Step 4 Introductory Training Presentation has been developed by the E8(R1) Expert Working Group and is now available on the ICH E8(R1) webpage with the Step 4 ICH E8(R1) Guideline. World Health Organization (WHO).

Pharmaceutical Industry 40

Pharmaceutical Industry FDA Hospitals World Health 40

Bill of Health

OCTOBER 31, 2024

Food and Drug Administration (FDA) is expected to propose new rulemaking on front-of-package labeling in 2024. The World Health Organization (WHO) has recommended FOP labeling as a cost-effective intervention to improve population-level dietary habits. Since 2009, the U.S. No standardized system exists but the U.S.

Public Health 100

Public Health FDA Governance Licensing 100

Bill of Health

MARCH 27, 2023

The more bees present in a confined area, the greater the risk of being infected. All of this might make sense in a world where COVID has gradually become less prevalent and less of threat. But, if that world exists, it is somewhere in another dimension. In this framework, the CDC was treating cases of the virus like angry bees.

COVID-19 334

COVID-19 Public Health Governance COVID-19 Vaccine 334

SQA

OCTOBER 18, 2022

The ICH M12 Draft Guideline Presentation Available Now on the ICH Website, 15 July 2022. A Step 2 Informational Presentation has been developed by the M12 Expert Working Group, in follow up to the ICH M12 draft Guideline on Drug Interaction Studies reaching Step 2b of the ICH Process on 24 May 2022. PDA Technical Report No.

US Department of Health and Human Services 40

US Department of Health and Human Services FDA COVID-19 Compliance 40

SQA

FEBRUARY 26, 2024

During the operation, food supplements, cannabidiol in various presentations, testosterone, perfumes, and sibutramine tablets were identified, including about 6,000 units of electronic cigarettes and 35,500 packs of cigarettes. The products found, subject to retention and seizure, were retained by the Federal Revenue Service.

FDA 52

FDA Compliance COVID-19 Public Health 52

SQA

FEBRUARY 26, 2024

During the operation,food supplements,cannabidiolin various presentations, testosterone, perfumes, and sibutramine tabletswere identified,including about 6,000 units of electronic cigarettes and35,500packs of cigarettes.The products found, subject to retention and seizure, were retained by the Federal Revenue Service.

FDA 40

FDA Compliance COVID-19 Public Health 40

Hall Render

JANUARY 24, 2025

Lukes celebrates new vascular, interventional radiology labs UI Health Care secures $252.6 million bond for hospital projects amid market volatility UnityPoint Health St. Reynolds presented plans to tackle Iowas physician shortage. Luke’s opens new section Gov. How will they help?

US Department of Health and Human Services 40

US Department of Health and Human Services Nursing Homes Nurses Hospitals 40

Drug & Device Law

DECEMBER 27, 2022

Filing a citizen’s petition, Valisure shocked the FDA into an ill-advised recall by reporting that “tests found NDMA in ranitidine in excess of 3,000,000 ng [nanograms] per pill” – far above FDA’s 96 ng/day “daily limit.” The FDA recognized these results as bogus, “conclud[ing] that. . . 2022 WL 17480906, at *1.

FDA 59

FDA World Health Governance 59